Crestline Management, LP Astrazeneca PLC Transaction History
Crestline Management, LP
- $2.93 Billion
- Q4 2024
A detailed history of Crestline Management, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Crestline Management, LP holds 37,335 shares of AZN stock, worth $2.79 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
37,335
Previous 61,269
39.06%
Holding current value
$2.79 Million
Previous $4.77 Million
48.76%
% of portfolio
0.08%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,353Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.51 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.07 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.81 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.77 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.8 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $232B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...